Impact of E-cigarette Characteristics on Reinforcement and Tobacco Use Patterns

December 11, 2023 updated by: Tracy Smith, Medical University of South Carolina

Impact of E-cigarette Characteristics on Reinforcement and Tobacco Use Patterns Among

The purpose of this project is to understand how different e-cigarettes influence their likeability and use among current smokers who try using e-cigarettes. Participants will receive an e-cigarette to sample over a three week period. During this time period they will complete daily electronic diaries and weekly lab visits. The results from this information will help understand how different types of e-cigarettes are likely to influence cigarette and e-cigarette use.

Study Overview

Study Type

Interventional

Enrollment (Actual)

92

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Matt Carpenter, PhD

Study Locations

    • South Carolina
      • Charleston, South Carolina, United States, 29425
        • Medical University of South Carolina

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion criteria include

  • adults who have been smoking daily
  • interested in using e-cigarettes
  • who have a smartphone that can receive text messages and access to the internet or has an e-mail account that they check daily

Exclusion criteria include

  • minimal prior e-cigarette use
  • use of tobacco products other than cigarettes
  • current use of cessation medications
  • pregnant, trying to become pregnant, or breastfeeding,
  • recent history of cardiovascular distress in the last three months (e.g., arrhythmia, heart attack, stroke, uncontrolled hypertension),
  • household member currently enrolled in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Low Concentration / Low Power
Participant will receive an e-liquid with a low nicotine concentration and an e-cigarette with a low power for three weeks.
Participants will receive a low power e-cigarette to use for 3 weeks
Participants will receive a low concentration e-liquid to use for 3 weeks
Experimental: Low Concentration / High Power
Participant will receive an e-liquid with a low nicotine concentration and an e-cigarette with a high power for three weeks.
Participants will receive a low concentration e-liquid to use for 3 weeks
Participants will receive a high power e-cigarette to use for 3 weeks
Experimental: High Concentration / Low Power
Participant will receive an e-liquid with a high nicotine concentration and an e-cigarette with a low power for three weeks.
Participants will receive a low power e-cigarette to use for 3 weeks
Participants will receive a high concentration e-liquid to use for 3 weeks
Experimental: High Concentration / High Power
Participant will receive an e-liquid with a high nicotine concentration and an e-cigarette with a high power for three weeks.
Participants will receive a high power e-cigarette to use for 3 weeks
Participants will receive a high concentration e-liquid to use for 3 weeks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mean Cigarettes Per Day
Time Frame: up to 3 weeks
Participants complete daily electronic diaries reporting the number of cigarettes smoked each day on a continuous scale
up to 3 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Average Number of E-cigarette Puffing Episodes
Time Frame: up to 3 Weeks
Participants complete daily electronic diaries reporting the number of e-cigarette puffing episodes each day on a continuous scale
up to 3 Weeks
Number of Choices to Smoke Cigarette in Lab Setting
Time Frame: Week 3
Participants complete lab-based choice task at Week 3 visit in which they choose between smoking conventional cigarette and e-cigarette over 10 trials. Outcome is number of times each participant chooses to smoke conventional cigarette.
Week 3

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tracy Smith, PhD, Medical University of South Carolina

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2019

Primary Completion (Actual)

October 17, 2023

Study Completion (Actual)

November 9, 2023

Study Registration Dates

First Submitted

February 14, 2019

First Submitted That Met QC Criteria

February 14, 2019

First Posted (Actual)

February 18, 2019

Study Record Updates

Last Update Posted (Estimated)

December 12, 2023

Last Update Submitted That Met QC Criteria

December 11, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 00081069
  • K01DA047433 (U.S. NIH Grant/Contract)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking

Clinical Trials on Low Power

3
Subscribe